Cargando…

Superior infectivity of the fiber chimeric oncolytic adenoviruses Ad5/35 and Ad5/3 over Ad5-delta-24-RGD in primary glioma cultures

Ad5-delta-24-RGD is currently the most clinically advanced recombinant adenovirus (rAd) for glioma therapy. We constructed a panel of fiber-modified rAds (Ad5RGD, Ad5/3, Ad5/35, Ad5/3RGD, and Ad5/35RGD, all harboring the delta-24 modification) and compared their infectivity, replication, reproductio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stepanenko, Aleksei A., Sosnovtseva, Anastasiia O., Valikhov, Marat P., Chernysheva, Anastasia A., Cherepanov, Sergey A., Yusubalieva, Gaukhar M., Ruzsics, Zsolt, Lipatova, Anastasiia V., Chekhonin, Vladimir P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761956/ https://www.ncbi.nlm.nih.gov/pubmed/35071746 http://dx.doi.org/10.1016/j.omto.2021.12.013

Ejemplares similares

A new insight into aggregation of oncolytic adenovirus Ad5-delta-24-RGD during CsCl gradient ultracentrifugation
por: Stepanenko, Aleksei A., et al.
Publicado: (2021)

In Vivo Tracking for Oncolytic Adenovirus Interactions with Liver Cells
por: Naumenko, Victor A., et al.
Publicado: (2022)

Recombinant Adenoviruses for Delivery of Therapeutics Following Spinal Cord Injury
por: Sosnovtseva, Anastasiia O., et al.
Publicado: (2022)

Infection of non-cancer cells: A barrier or support for oncolytic virotherapy?
por: Naumenko, Victor A., et al.
Publicado: (2022)

Rodents Versus Pig Model for Assessing the Performance of Serotype Chimeric Ad5/3 Oncolytic Adenoviruses
por: Koodie, Lisa, et al.
Publicado: (2019)

Intravenous administration of the conditionally replicative adenovirus Ad5-Δ24RGD induces regression of osteosarcoma lung metastases
por: Graat, Harm CA, et al.
Publicado: (2008)

Oncolytic adenovirus Ad657 for systemic virotherapy against prostate cancer
por: Nguyen, Tien V, et al.
Publicado: (2018)

Ad 2.0: a novel recombineering platform for high-throughput generation of tailored adenoviruses
por: Mück-Häusl, Martin, et al.
Publicado: (2015)

Different memory T cell phenotypes are elicited by Ad5 and rare adenoviruses
por: Penaloza, P, et al.
Publicado: (2012)

Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions
por: Yang, Wei-Xiong, et al.
Publicado: (2016)

Baseline Ad5 serostatus does not predict Ad5-HIV vaccine-induced expansion of Ad-specific CD4+ T-cells
por: Hutnick, Natalie A., et al.
Publicado: (2009)

Transient Chimeric Ad5/37 Fiber Enhances NK-92 Carrier Cell-Mediated Delivery of Oncolytic Adenovirus Type 5 to Tumor Cells
por: Gao, Jian, et al.
Publicado: (2020)

HDAC Inhibitors Enhance Efficacy of the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T in Pancreatic and Triple-Negative Breast Cancer Models
por: Rodríguez, María Del Carmen Rodríguez, et al.
Publicado: (2022)

Twistor methods for AdS$_5$
por: Adamo, Tim, et al.
Publicado: (2016)

Quantum Fishchain in $AdS_5$
por: Gromov, Nikolay, et al.
Publicado: (2019)

Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and Adenovirus (Ad5) immune mice
por: Schuldt, Nathaniel J, et al.
Publicado: (2012)

Altering the Ad5 Packaging Domain Affects the Maturation of the Ad Particles
por: Alba, Raul, et al.
Publicado: (2011)

Evaluation of Novel Large Cut-Off Ultrafiltration Membranes for Adenovirus Serotype 5 (Ad5) Concentration
por: Nestola, Piergiuseppe, et al.
Publicado: (2014)

Complexing the Oncolytic Adenoviruses Ad∆∆ and Ad-3∆-A20T with Cationic Nanoparticles Enhances Viral Infection and Spread in Prostate and Pancreatic Cancer Models
por: Man, Yang Kee Stella, et al.
Publicado: (2022)

Recent Developments in Glioblastoma Therapy: Oncolytic Viruses and Emerging Future Strategies
por: Hamad, Azzam, et al.
Publicado: (2023)

Oncolytic Efficacy of a Recombinant Vaccinia Virus Strain Expressing Bacterial Flagellin in Solid Tumor Models
por: Shakiba, Yasmin, et al.
Publicado: (2023)

Differential immunogenicity between HAdV-5 and chimpanzee adenovirus vector ChAdOx1 is independent of fiber and penton RGD loop sequences in mice
por: Dicks, Matthew D. J., et al.
Publicado: (2015)

Adenovirus-Specific Immunity Following Immunization with an Ad5 HIV-1 Vaccine Candidate in Humans
por: O’Brien, Kara L., et al.
Publicado: (2009)

rAd5/NYVAC-B is superior to NYVAC-B/rAd5 and is dependent on rAd5 dose for neutralizing antibody responses against HIV-1
por: Montefiori, DC, et al.
Publicado: (2012)

Oncolytic therapy with recombinant vaccinia viruses targeting the interleukin-15 pathway elicits a synergistic response
por: Shakiba, Yasmin, et al.
Publicado: (2023)

$AdS_{5}$ Superalgebras with Brane Charges
por: Ferrara, S., et al.
Publicado: (1999)

Vaccination with Ad5 Vectors Expands Ad5-Specific CD8(+) T Cells without Altering Memory Phenotype or Functionality
por: Hutnick, Natalie A., et al.
Publicado: (2010)

Recent Advances in Oncolytic Virotherapy and Immunotherapy for Glioblastoma: A Glimmer of Hope in the Search for an Effective Therapy?
por: Stepanenko, Aleksei A., et al.
Publicado: (2018)

Sensitisation to mitoxantrone-induced apoptosis by the oncolytic adenovirus Ad∆∆ through Bcl-2-dependent attenuation of autophagy
por: Aguirre-Hernández, Carmen, et al.
Publicado: (2018)

ALPHA (AD-5) Status Report for 2014
por: Hangst, JS
Publicado: (2015)

$AdS_{5}$ and the 4D Cosmological Constant
por: Schmidhuber, Christof
Publicado: (1999)

Tools for deconstructing gauge theories in AdS(5)
por: de Blas, Jorge, et al.
Publicado: (2006)

Microstates of supersymmetric black holes in AdS5
por: Murthy, Sameer
Publicado: (2021)

Microstates of supersymmetric black holes in AdS5
por: Murthy, Sameer
Publicado: (2021)

Microstates of supersymmetric black holes in AdS5
por: Murthy, Sameer
Publicado: (2021)

Microstates of supersymmetric black holes in AdS5
por: Murthy, Sameer
Publicado: (2021)

Influence of cell physiological state on gene delivery to T lymphocytes by chimeric adenovirus Ad5F35
por: Zhang, Wen-feng, et al.
Publicado: (2016)

Antitumor‐specific T‐cell responses induced by oncolytic adenovirus ONCOS‐102 (AdV5/3‐D24‐GM‐CSF) in peritoneal mesothelioma mouse model
por: Kuryk, Lukasz, et al.
Publicado: (2018)

Modification of Ad5 Hexon Hypervariable Regions Circumvents Pre-Existing Ad5 Neutralizing Antibodies and Induces Protective Immune Responses
por: Bruder, Joseph T., et al.
Publicado: (2012)

Intracardiac injection of a capsid-modified Ad5/35 results in decreased heart toxicity when compared to standard Ad5
por: Toivonen, Raine, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_0q1n5llng5dhbrob7kad83a0tg